Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 17, 2012British Journal of Pharmacology

A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2‐arachidonoylglycerol with potential anti‐obesity effects

View Full Paper
Ask AI
Bookmark
Share

Authors

TBTiziana BisognoIstituto di Farmacologia TraslazionaleAMAnu MahadevanOrganix (United States)RCRoberto CoccurelloEuropean Brain Research Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bisogno et al. (2012) studied this question.

synapsesocial.com/papers/6a8968af2d856b866692ce17https://doi.org/10.1111/bph.12013
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Animal research: Reporting <i>in vivo</i> experiments: The ARRIVE guidelines2010 · 3,670 citations
  2. 2Cannabinoid-1 receptor antagonists reduce caloric intake by decreasing palatable diet selection in a novel dessert protocol in female rats2008 · 51 citations